Metastatic Malignant Melanoma



Metastatic Malignant Melanoma











Gross appearance of a bisected nodule image containing a lung metastasis of malignant melanoma shows a well-circumscribed tan nodule with an area of black discoloration due to melanin pigment deposition.






Histologic appearance of metastatic malignant melanoma in the lung shows nests of large, epithelioid tumor cells with enlarged nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm.


CLINICAL ISSUES


Epidemiology



  • Incidence



    • Lung is frequent site of metastasis for malignant melanoma


  • Age



    • Middle-aged to elderly patients


Presentation



  • Cough


  • Hemoptysis


  • Dyspnea


  • Atelectasis


  • Pleural effusion


Treatment



  • Surgical approaches



    • Surgical excision for solitary lesions may improve median survival


  • Adjuvant therapy



    • Chemotherapy may be used for multiple and bilateral tumors


Prognosis



  • Melanoma metastases to lungs are associated with advanced stage and poor prognosis


IMAGE FINDINGS


General Features



  • Location



    • Multiple, well-defined nodules in periphery of lungs


    • Endobronchial metastases


  • Morphology



    • Round, well-defined nodules


    • Can show cavitation and necrosis


MACROSCOPIC FEATURES


General Features



  • Usually well circumscribed but unencapsulated


  • Tan or white, homogeneous cut surface with areas of hemorrhage and necrosis


  • Tumors may be deeply pigmented due to heavy melanin deposition


Size



  • Several millimeters to > 5 cm in greatest diameter


MICROSCOPIC PATHOLOGY


Histologic Features



  • Epithelioid melanoma



    • Nests or islands of large epithelioid cells with abundant eosinophilic cytoplasm that may resemble carcinoma


    • Tumor cells contain enlarged nuclei with prominent nucleoli


  • Spindle cell melanoma



    • Nests or short fascicles of atypical spindle cells resembling sarcoma


    • Differential diagnosis includes sarcomatoid lung carcinoma, metastatic sarcomatoid renal cell carcinoma, and spindle cell sarcoma


  • Mixed spindle and epithelioid cell melanoma



    • Most common form of metastatic melanoma, showing admixture of both spindle and epithelioid cells


    • Can be confused for a variety of other primary and metastatic sarcomas in the lung


  • Pleomorphic melanoma



    • Characterized by sheets of pleomorphic and anaplastic tumor cells with bizarre nuclei and frequent abnormal mitoses
      METASTATIC MALIGNANT MELANOMA


    • Tumors may resemble pleomorphic high-grade sarcoma (MFH) or pleomorphic/anaplastic carcinoma of lung


  • “Rhabdoid” melanoma



    • Composed of sheets of large tumor cells with eccentric, densely eosinophilic cytoplasmic inclusions


    • Tumor cells can resemble rhabdomyoblastic cells in rhabdomyosarcoma or in “malignant rhabdoid tumor”


  • Signet ring cell melanoma



    • Sheets of tumor cells characterized by signet ring cell morphology


    • Cells will show enlarged, hyperchromatic nuclei displaced to periphery by abundant cytoplasm


  • Small cell melanoma



    • Dense sheets of monotonous small round tumor cells with hyperchromatic nuclei and scant cytoplasm


    • Tumors can resemble malignant lymphoma, carcinoid tumors, and other small round blue cell tumors


Cytologic Features



  • Hallmark of malignant melanoma is presence of cells with marked cytologic atypia


  • Majority of tumor cells are large, pleomorphic, with enlarged nuclei and prominent eosinophilic nucleoli


  • Frequent mitotic figures; abnormal mitoses are often encountered


  • Cells may also be small and relatively bland-appearing with minimal cytologic atypia


ANCILLARY TESTS


Immunohistochemistry



  • S100 protein is positive in nearly 100% of cases (nuclear and cytoplasmic stain)


  • In most cases, melanocytic-associated markers are positive: HMB-45, Melan-A, tyrosinase, microphthalmia transcription factor (MiTF)


  • Aberrant expression of epithelial markers (keratins, CEA, EMA) can be seen in small percentage of cases


  • Other markers can also be expressed, including CD10, CD56, CD68, CD99, CD117, calretinin, NSE, vimentin, and Bcl-2, but are nonspecific


DIFFERENTIAL DIAGNOSIS


Sarcomatoid Carcinoma



  • Tumor cells are positive for epithelial markers (cytokeratin, EMA, MOC31) and negative for S100 and melanocytic markers


Metastatic Renal Cell Carcinoma



  • Can show similar morphology with nests of tumor cells with abundant eosinophilic or granular cytoplasm


  • Tumor cells are positive for cytokeratin, EMA, and RCC marker, and negative for melanoma-associated markers and S100


Spindle and Epithelioid Cell Sarcomas

Jul 9, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Metastatic Malignant Melanoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access